Alloxan diabetes was induced in inbred rats that then were divided into four groups consisting of unoperated diabetic controls, sham-operated diabetic controls, rats given pancreaticoduodenal isografts, and rats given duct-ligated pancreas isografts. The animals were studied for from 18 months (controls) to two years (transplants) and the following important results were obtained: 1) In striking contrast to the diabetic controls, pancreas transplants of both types produced immediate and permanent relief of hyperglycemia, immediate and lasting elevation of serum insulin levels, a normal weight and growth curve, and good health for two years. Removal of the graft was followed by recurrence of severe diabetes. 2) Pancreas transplants of both types prevented the widespread and severe renal, ophthalmic and neural lesions of diabetes that were found in the diabetic controls.
Alloxan diabetes was induced in inbred rats that then were divided into four groups consisting of unoperated diabetic controls, sham-operated diabetic controls, rats given pancreaticoduodenal isografts, and rats given duct-ligated pancreas isografts. The animals were studied for from 18 months (controls) to two years (transplants) and the following important results were obtained: 1) In striking contrast to the diabetic controls, pancreas transplants of both types produced immediate and permanent relief of hyperglycemia, immediate and lasting elevation of serum insulin levels, a normal weight and growth curve, and good health for two years. Removal of the graft was followed by recurrence of severe diabetes. 2) Pancreas transplants of both types prevented the widespread and severe renal, ophthalmic and neural lesions of diabetes that were found in the diabetic controls.
3) The ductligated pancreas graft and pancreaticoduodenal transplant were equally effective in controlling diabetes. Ligation of the pancreatic duct was not followed by significant morphologic or clinical evidence of pancreatitis or by loss of endocrine function. 4) Portal venous drainage of the pancreas transplant was unnecessary for good endocrine function.
DIABETES MELLITUS is a very common disease that is responsible for substantial morbidity and mortality. It is estimated that more than 4.5 million people in the United States have diabetes, approximately one million of whom require insulin therapy for control of hyperglycemia.17 Currently, diabetes is the seventh ranking primary cause of death in this country, and it is a major contributor to deaths attributed to heart disease and stroke. Approximately one-quarter million individuals in the United States have juvenile-onset diabetes, the most severe form of the disease, and most of these develop nephropathy and retinopathy by the fourth decade of life regardless of how well their blood sugar levels have been controlled by available medical means. Substantial
From the Department of Surgery, School of Medicine, University of California, San Diego, La Jolla, California evidence indicates that current treatment of diabetes with insulin and diet has had little influence on the development of the widespread vascular lesions that complicate this condition. Although the etiology of diabetes mellitus is still not known, the weight of opinion favors the view that insufficiency of the islets of Langerhans is the primary abnormality, so that provision of physiological islet function might prevent the crippling and often lethal effects of the disease. Therefore, the clinical stimulus to research in pancreas transplantation is apparent.
If pancreas transplantation is to be useful in the treatment of diabetes mellitus, four important questions must be answered. The pancreaticoduodenal graft was transplanted to the recipient rat through a midline abdominal incision (Fig.  1 ). The recipient aorta and inferior vena cava below the level of the left renal vein were cleaned and occluded with a partial occlusion clamp. End-to-side vascular anastomoses were performed using continuous 9- similar to that of pancreaticoduodenal transplantation except that in harvesting the graft the pancreas was dissected free from the duodenum and its excretory ducts were meticulously ligated and divided at their junction with the bile duct ( Fig. 1 ).
Blood Glucose and Insulin and Clinical Observations
The concentrations of glucose and insulin in blood obtained from a tail vein, body weight, food and water consumption, and physical appearance were determined every two weeks for the first three months, and then monthly for up to two years. Plasma glucose was measured by a modification of the 0-toluidine method which involves the spectrophotometric detection of N-glucosylamine formed from the reaction of glucose with 0-toluidine in glacial acetic acid in the presence of heat. Serum insulin was measured by a double antibody radioimmunoassay according to the principle of Yalow and Berson,20 using the Pharmacia Phadebos kit.
Morphologic Studies
Complete autopsies were performed in the rats at the time of death, and tissue was obtained for study by both light and electron microscopy. Particular attention was given to examination of the host pancreas, graft pancreas, kidneys, eyes, peripheral nerves, brain and blood vessels. Sections of pancreas were stained with both hematoxylin and eosin and with Gomori's aldehyde fuchsin to demonstrate the beta cells in the islets of Langerhans. In addition, at intervals throughout the study, animals were sacrificed randomly to provide optimal material for evaluating the evolution of morphologic changes. Removal of the Transplant To assess further the effectiveness of pancreas transplants in controlling diabetes, the grafts were removed from 19 animals that had been relieved of diabetes, and the studies of blood glucose, serum insulin, body weight and physical appearance were continued to determine if diabetes would recur. Twelve pancreaticoduodenal transplants were removed, 11 at one year and one at two years postoperatively. Seven duct-ligated pancreas grafts were removed, one at 18 months, two at 20 months, three at 22 months and one at 25 months postoperatively. The excised grafts were examined microscopically. In addition, complete morphologic examinations were performed when these animals ultimately died.
Results

Blood Glucose
The mean blood glucose levels and the per cent of animals with blood glucose levels above 200 mg % in the four experimental groups are shown in Table 1 and Fig. 2 .
All of the animals had blood glucose concentrations greater than 200 mg % at the time of operation, one week after administration of alloxan. The hyperglycemia persisted in both the unoperated and sham-operated controls, and the diabetes was associated with a progressively increasing mortality rate so that few animals survived beyond 18 months. The blood glucose levels in the two control groups were not significantly different at any time (P>0. 10). In contrast, every animal with a pancreas transplant had an immediate and permanent reduction of the blood glucose level to normal for the two-year study period. The differences in blood glucose concentrations between the two groups with transplants and the two control groups were highly significant at all times (P<0.001). Control of hyperglycemia was equally effective in the two transplant groups, and there were no significant differences between them at any time (P= >0. 10).
Serum Insulin
The mean serum insulin levels and the per cent of animals with serum insulin levels below 1.0 ng/ml in the four experimental groups are shown in Table 2 and Fig. 3 . Following induction of alloxan diabetes, all of the rats developed a significant fall in serum insulin concentration.. In the unoperated and sham-operated diabetic control rats, the decline in serum insulin levels progressed so that by one year every animal had a serum insulin con- centration below 1.0 ng/ml. The serum insulin levels in the two control groups were not significantly different from each other at any time. In contrast, transplantation of the pancreas, with or without the duodenum, produced an immediate and persistent rise in serum insulin to levels that were significantly higher than those in the control groups at all times during the study (P=<0.001). The absolute levels of serum insulin in the transplanted animals gradually declined over the two-year study period, similar to what has been observed in the normal Lewis rat as it ages. Comparison of the serum insulin levels in the two transplant groups showed a significantly higher mean insulin concentration three months postoperatively in the rats with pancreaticoudodenal grafts, but no significant differences thereafter (P= >0.10). There was no evidence that the duct-ligated pancreas transplant secreted less insulin than the pancreaticoduodenal graft up to two years after transplantation. ody Weight Mean body weights of the four experimental groups are shown in Table 3 and Fig. 4 . All of the animals lost 40-50 gm of weight during the week following the injection of alloxan. The unoperated and sham-operated diabetic controls did not regain their pre-injection weights until 6 months later, and then gained weight at a rate far slower than that of normal Lewis rats. By 18 months, the mean weight of the two control groups was only 10% above their mean pre-alloxan weight. In contrast, the rats with pancreas transplants of either type regained their preinjection weight within one month postoperatively, and subsequently gained weight at a normal rate. The differences between the control and transplant groups were highly significant at all times. Except for measurements made at 9 months after operation, when the rats with duct-ligated pancreas transplants were significantly heavier than those with pancreaticoduodenal transplants, there were no significant weight differences 18 and 25 months after operation. Every animal had an immediate and sustained rise in blood glucose, an immediate and sustained fall in serum insulin, and a progressive loss of body weight following removal of the graft. In 17 of the 19 rats the blood glucose level exceeded 200 mg % and in eight it rose above 400 mg %. Recurrence of diabetes was accompanied by a progressive decline in health, and death of most of the rats within one month. As previous studies have demonstrated, these results indicate that alloxan diabetes is permanent, unlike diabetes induced with streptozotocin which frequently disappears with time.
Pancreas Pathology
Examination of the host pancreas at monthly intervals up to two years after exposure to alloxan showed collapse of the islets of Langerhans and permanent disappearance of almost all of the beta cells. There was no evidence of repair with time, and specimens examined two years after induction of diabetes were indistinguishable from those removed after one or two months.
Pancreaticoduodenal grafts examined serially up to two years after transplantation had all of the features of the normal pancreas of similar age. The acini, ducts and islets of Langerhans were well-preserved and beta cell granules were abundant.
The morphologic changes in the duct-ligated pancreas transplant were of particular interest. During the first two months after transplantation there was mild to moderate chronic inflammation consisting mainly of plasma cells and some lymphocytes. Subsequently, evidence of inflammation was absent or mild. The most striking features during the first several months were dilatation and proliferation of the pancreatic ducts accompanied by marked atrophy of the acini, moderate fibrosis and replacement of the parenchyma by fat. By one year, the parenchyma of the pancreas had undergone almost complete atrophy and consisted mainly of fat, some fibrous tissue and some dilated ducts. This picture underwent little change during The pathologic findings in the animals with both pancreaticoduodenal transplants and duct-ligated pancreas grafts were strikingly fewer and less severe than those seen in the diabetic controls. In large measure, transplantation of the pancreas prevented the systemic pathologic abnormalities associated with alloxan diabetes for the life span of the rat.
Discussion
The results of this study indicate clearly that pancreas transplants were consistently capable of good endocrine function and control of alloxan-induced diabetes throughout the normal two-year life span of the rat. The permanent nature of alloxan diabetes and its cure by transplantation of the pancreas were confirmed by the prompt recurrence of the disease following removal of the grafts at intervals ranging from one to two years postoperatively.
Of potentially more far-reaching consequence, the results of this study show that pancreas transplantation prevented the widespread systemic manifestations of diabetes mellitus. The diabetic control rats developed severe pathologic abnormalities in the kidneys, eyes and nerves, many of which were similar to those that have been observed in the human disease. The By all criteria used in this study, the duct-ligated pancreas transplants were as effective as pancreaticoduodenal grafts in controlling diabetes. Moreover, the operative mortality rate associated with transplantation of the duct-ligated pancreas was lower than that of pancreaticoduodenal transplantation, and there was no clinical evidence of pancreatitis or toxicity. The characteristic morphologic features of the ductligated pancreas were dilatation of the ducts and atrophy of the acini, not pancreatitis, and the islet tissue, although fragmented, remained viable with abundant beta cell granules.
There have been conflicting reports regarding the necessity of providing venous drainage of pancreas transplants into the portal system. Some investigators have suggested that systemic venous drainage results in high serum insulin levels and hypoglycemia because of bypass of hepatic insulin metabolism. 16 However, the reason I rise to discuss this is to mention the insulin and glucogon levels in animals that received isolated islet transplants. These levels were determined 10-12 months following transplantation.
The interesting observation is that, in comparison with findings in
